Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis

A. Uccelli, E. Capello, D. Fenoglio, M. Incagliato, M. Valbonesi, G. L. Mancardi

Research output: Contribution to journalArticle

Abstract

Five patients with a severe form of chronic progressive multiple sclerosis no longer responsive to steroid therapy were treated for six months with high-dose intravenous immunoglobulin associated with plasmalymphocytapheresis and azathioprine. In spite of an apparent initial stabilization of the course of the disease, EDSS assesment after six and twelve months of therapy revealed progressive disability in all patients.

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalItalian Journal of Neurological Sciences
Volume15
Issue number1
DOIs
Publication statusPublished - Feb 1994

Keywords

  • azathioprine
  • chronic progressive multiple sclerosis
  • intravenous immunoglobulin
  • plasmalymphocytapheresis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this